Intrautrine Growth Restriction - IUGR

Cochrane Database Syst Rev. 2003;(1):CD000109.

Hormones for suspected impaired fetal growth.
Say L, G?mezoglu AM, Hofmeyr GJ.

Department of Reproductive Health and Research, World Health Organization, 20 Avenue Appia, Geneva 27, Switzerland. sayl@who. Int

Background:

It has been suggested that oestrogens may improve fetal growth due to an increase in nutritional supply to the fetus from greater uterine blood flow.

Objectives:

The objective of this review was to assess the effects of hormone administration for suspected impaired fetal growth and perinatal outcome.

Search Strategy:

We searched the Cochrane Pregnancy and Childbirth Group trials register (1 November 2002).

Selection Criteria:

Acceptably controlled trials of hormone administration for suspected impaired fetal growth which report fetal, perinatal or maternal outcomes. DATA COLLECTION AND ANALYSIS: Eligibility and trial quality were assessed. MAIN

Results:

No studies were included since none of the potentially relevant trials reported clinical outcomes. REVIEWER'S

Conclusions:

There is not enough evidence to evaluate the clinical use of hormone administration for suspected impaired fetal growth.